BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dreyer NA, Reynolds M, DeFilippo Mack C, Brinkley E, Petruski-Ivleva N, Hawaldar K, Toovey S, Morris J. Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis. Travel Med Infect Dis 2020;38:101909. [PMID: 33152512 DOI: 10.1016/j.tmaid.2020.101909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Reynolds MW, Secora A, Joules A, Albert L, Brinkley E, Kwon T, Mack C, Toovey S, Dreyer NA. Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design. J Comp Eff Res 2022. [PMID: 36148919 DOI: 10.2217/cer-2022-0069] [Reference Citation Analysis]
2 Reynolds MW, Xie Y, Knuth KB, Mack CD, Brinkley E, Toovey S, Dreyer NA. . IDR 2022;Volume 15:5167-82. [DOI: 10.2147/idr.s373183] [Reference Citation Analysis]
3 Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2022;5:CD013665. [PMID: 35593186 DOI: 10.1002/14651858.CD013665.pub3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Munsch N, Gruarin S, Nateqi J, Lutz T, Binder M, Aberle JH, Martin A, Knapp B. Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna. Wien Klin Wochenschr 2022. [PMID: 35416543 DOI: 10.1007/s00508-022-02028-9] [Reference Citation Analysis]
5 Antonarelli M, Fogante M. Chest CT-Derived Muscle Analysis in COVID-19 Patients. Tomography 2022;8:414-22. [DOI: 10.3390/tomography8010034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Dreyer N, Reynolds MW, Albert L, Brinkley E, Kwon T, Mack C, Toovey S. How frequent are acute reactions to COVID-19 vaccination and who is at risk? Vaccine 2022. [DOI: 10.1016/j.vaccine.2021.12.072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Richard SA, Epsi NJ, Pollett S, Lindholm DA, Malloy AMW, Maves R, Utz GC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Chi SW, Huprikar N, Larson DT, Bazan S, Madar C, Lanteri C, Rozman JS, English C, Mende K, Tribble DR, Agan BK, Burgess TH, Powers JH 3rd; Epidemiology, Immunology, and Clinical Characteristics of Pandemic Infectious Diseases (EPICC) COVID-19 Cohort Study Group . Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019. Open Forum Infect Dis 2021;8:ofab517. [PMID: 34901299 DOI: 10.1093/ofid/ofab517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Pang KW, Tham SL, Ng LS. Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review. Life (Basel) 2021;11:1315. [PMID: 34947846 DOI: 10.3390/life11121315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Meystre SM, Heider PM, Kim Y, Davis M, Obeid J, Madory J, Alekseyenko AV. Natural Language Processing Enabling COVID-19 Predictive Analytics to Support Data-Driven Patient Advising and Pooled Testing. J Am Med Inform Assoc 2021:ocab186. [PMID: 34415311 DOI: 10.1093/jamia/ocab186] [Reference Citation Analysis]
10 Dreyer N, Petruski-Ivleva N, Albert L, Mohamed D, Brinkley E, Reynolds M, Toovey S. Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19. Int J Gen Med 2021;14:3941-9. [PMID: 34345182 DOI: 10.2147/IJGM.S313486] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Wagner A, Guzek A, Ruff J, Jasinska J, Scheikl U, Zwazl I, Kundi M, Stockinger H, Farcet MR, Kreil TR, Hoeltl E, Wiedermann U. Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00012-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]